Passage Bio Q2 EPS $(2.96) Misses $(0.21) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings MissesNews
Passage Bio (NASDAQ:PASG) reported quarterly losses of $(2.96) per share which missed the analyst consensus estimate of $(0.21) by 1309.52 percent. This is a 41.85 percent increase over losses of $(5.09) per share from
Passage Bio (NASDAQ:PASG) reported quarterly losses of $(2.96) per share which missed the analyst consensus estimate of $(0.21) by 1309.52 percent. This is a 41.85 percent increase over losses of $(5.09) per share from the same period last year.